section name header

Y-Site Injection Compatibility (1:1 Mixture)

Ceftazidime

(Mfr: GSK)(Conc: 200 mg/mLf)

I

Ibuprofen lysine

(Mfr: OVA)(Conc: 10 mg/mL)

Remarks:

Slight turbidity increase

Ref:

3541